Treace Medical Concepts Inc Cash Flow-to-Debt Ratio
Treace Medical Concepts Inc cash flow-to-debt ratio. Treace Medical Concepts Inc (TMCI) has a Cash Flow-to-Debt Ratio of 0.07x as of March 2026, meaning its operating cash flow of $7.23 Million could theoretically repay 0% of its total liabilities ($106.91 Million) in one year. Check Treace Medical Concepts Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Treace Medical Concepts Inc (2019–2025)
Cash flow-to-debt ratio of Treace Medical Concepts Inc from 2019 to 2025. Historical debt coverage capacity for Treace Medical Concepts Inc across 7 annual periods. Check Treace Medical Concepts Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Treace Medical Concepts Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Treace Medical Concepts Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Treace Medical Concepts Inc. For the full cash flow conversion analysis, see Treace Medical Concepts Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.15x | $-15.97 Million | $103.25 Million | ▲ +56.6% |
| 2024 | -0.36x | $-37.17 Million | $104.20 Million | ▼ -17.6% |
| 2023 | -0.30x | $-34.58 Million | $113.97 Million | ▲ +2.5% |
| 2022 | -0.31x | $-30.65 Million | $98.50 Million | ▲ +13.6% |
| 2021 | -0.36x | $-17.19 Million | $47.75 Million | ▼ -228.8% |
| 2020 | -0.11x | $-4.49 Million | $41.03 Million | ▲ +62.1% |
| 2019 | -0.29x | $-7.67 Million | $26.55 Million | — |